WO2012017128A2 - Composition based on rosemary extract and vitamin e and uses thereof - Google Patents
Composition based on rosemary extract and vitamin e and uses thereof Download PDFInfo
- Publication number
- WO2012017128A2 WO2012017128A2 PCT/ES2011/070586 ES2011070586W WO2012017128A2 WO 2012017128 A2 WO2012017128 A2 WO 2012017128A2 ES 2011070586 W ES2011070586 W ES 2011070586W WO 2012017128 A2 WO2012017128 A2 WO 2012017128A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- rosemary extract
- composition based
- menopause
- treating
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 229940092258 rosemary extract Drugs 0.000 title abstract 2
- 235000020748 rosemary extract Nutrition 0.000 title abstract 2
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 title abstract 2
- 229940088594 vitamin Drugs 0.000 title 1
- 229930003231 vitamin Natural products 0.000 title 1
- 235000013343 vitamin Nutrition 0.000 title 1
- 239000011782 vitamin Substances 0.000 title 1
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000005865 ionizing radiation Effects 0.000 abstract 1
- 230000003859 lipid peroxidation Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000009245 menopause Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The composition comprises a rosemary extract and vitamin E, and may be used as a nutritional supplement and also in the production of pharmaceutical compositions for reducing inflammatory processes and lipid peroxidation in general and, in particular, processes associated with the menopause, and also for preventing and/or treating the adverse effects of ionizing radiation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201031225A ES2374482B1 (en) | 2010-08-05 | 2010-08-05 | COMPOSITION FOR REDUCTION OF SYMPTOMS ASSOCIATED WITH MENOPAUSE. |
ESP201031225 | 2010-08-05 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2012017128A1 WO2012017128A1 (en) | 2012-02-09 |
WO2012017128A2 true WO2012017128A2 (en) | 2012-02-09 |
WO2012017128A3 WO2012017128A3 (en) | 2012-03-08 |
Family
ID=45541172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2011/070586 WO2012017128A2 (en) | 2010-08-05 | 2011-08-05 | Composition based on rosemary extract and vitamin e and uses thereof |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2374482B1 (en) |
WO (1) | WO2012017128A2 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040048919A1 (en) * | 2002-07-02 | 2004-03-11 | Dreon Darlene M. | Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects |
US20070141170A1 (en) * | 2005-12-20 | 2007-06-21 | Alcon Manufacturing, Ltd. | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
US20070253941A1 (en) * | 2006-04-28 | 2007-11-01 | Naidu A Satyanarayan | Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof |
WO2007141764A1 (en) * | 2006-06-08 | 2007-12-13 | The Iams Company | Use of at least one polyphenol for promoting eye health |
EP1902631A2 (en) * | 2006-09-19 | 2008-03-26 | Institut National de Recherche Agronomique | Plant-based natural antioxidant additive intended for animal nutrition |
WO2009136410A2 (en) * | 2008-04-19 | 2009-11-12 | Nisarga Biotech Pvt. Ltd. | Herbal composition for reducing add/adhd and method thereof |
US20100048512A1 (en) * | 2006-12-01 | 2010-02-25 | National Institute Of Radiological Sciences | Radiation protection drug containing tocopherol or tocotrienol compound ester derivative as active ingredient |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6352712B1 (en) * | 1999-04-30 | 2002-03-05 | Daniel O. Lukaczer | Dietary supplements for treating fatigue-related syndromes |
NO20081487L (en) * | 2008-03-27 | 2009-09-28 | Smartfish As | Health promoting drink |
US20100178369A1 (en) * | 2009-01-15 | 2010-07-15 | Nicole Lee Arledge | Antioxidant-stabilized concentrated fish oil |
-
2010
- 2010-08-05 ES ES201031225A patent/ES2374482B1/en not_active Expired - Fee Related
-
2011
- 2011-08-05 WO PCT/ES2011/070586 patent/WO2012017128A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040048919A1 (en) * | 2002-07-02 | 2004-03-11 | Dreon Darlene M. | Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects |
US20070141170A1 (en) * | 2005-12-20 | 2007-06-21 | Alcon Manufacturing, Ltd. | Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
US20070253941A1 (en) * | 2006-04-28 | 2007-11-01 | Naidu A Satyanarayan | Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof |
WO2007141764A1 (en) * | 2006-06-08 | 2007-12-13 | The Iams Company | Use of at least one polyphenol for promoting eye health |
EP1902631A2 (en) * | 2006-09-19 | 2008-03-26 | Institut National de Recherche Agronomique | Plant-based natural antioxidant additive intended for animal nutrition |
US20100048512A1 (en) * | 2006-12-01 | 2010-02-25 | National Institute Of Radiological Sciences | Radiation protection drug containing tocopherol or tocotrienol compound ester derivative as active ingredient |
WO2009136410A2 (en) * | 2008-04-19 | 2009-11-12 | Nisarga Biotech Pvt. Ltd. | Herbal composition for reducing add/adhd and method thereof |
Non-Patent Citations (1)
Title |
---|
PENG, C.-H. ET AL.: 'Supercritical fluid extracts of rosemary leaves exhibit potent anti-inflammation and anti-tumor effects.' BIOSCIENCE, BIOTECHNOLOGY AND BIOCHEMISTRY vol. 71, no. 9, 2007, ISSN 1347-6947 pages 2223 - 2232 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012017128A3 (en) | 2012-03-08 |
ES2374482A1 (en) | 2012-02-17 |
ES2374482B1 (en) | 2012-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008153945A3 (en) | Nutraceutical co-crystal compositions | |
PH12021550756A1 (en) | Compositions and methods for treating and/or preventing cardiovascular disease | |
WO2016086206A8 (en) | Probiotic compositions containing clostridiales for inhibiting inflammation | |
WO2014188276A3 (en) | Antioxidant compositions and methods of using the same | |
WO2010000877A3 (en) | Formulation with irritation reducing action comprising bisabolol and [6]-paradol | |
NZ611606A (en) | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity | |
WO2014179629A8 (en) | Compositions and methods | |
WO2009050580A8 (en) | Composition for regulating lipid metabolism | |
EA033311B1 (en) | Benzoxaborole derivatives as antibacterial agents | |
WO2014057362A3 (en) | Omega -3 compositions | |
MX2020009699A (en) | L-ornithine phenyl acetate and methods of making thereof. | |
IN2015DN03069A (en) | ||
EP3878445A3 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
WO2013150386A3 (en) | Compositions comprising omega-3 fatty acids and vitamin d for acne vulgaris and/or eczema, and methods and uses thereof | |
PH12017500641A1 (en) | Nutritional compositions comprising an oxidizablecomponent and water-soluble plant extract | |
WO2012049222A3 (en) | Novel omega-3 and omega-6 fatty acid compositions and uses thereof | |
WO2015067336A3 (en) | Conjugated polymers | |
PH12014500859A1 (en) | Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof | |
WO2014043230A3 (en) | Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof | |
WO2015003021A3 (en) | Dietary supplements and composition for treating cancer | |
MX2017009929A (en) | Compositions and methods for improved muscle metabolism. | |
MY155615A (en) | Nutritional compositions comprising fruit flakes containing docosahexaenoic acid | |
WO2013100718A3 (en) | Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient | |
WO2010046458A3 (en) | Compositions comprising vitamins | |
WO2012134172A3 (en) | Composition containing, as an active ingredient, an ethyl acetate fraction of schisandra chinensis baill, or wuweizisu c separated from the fraction, for preventing or treating obesity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11814154 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11814154 Country of ref document: EP Kind code of ref document: A2 |